Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography

Publication ,  Journal Article
Christenson, RH; Ohman, EM; Topol, EJ; O'Hanesian, MA; Sigmon, KN; Duh, SH; Kereiakes, D; Worley, SJ; George, BS; Pizzo, CK; Wall, TC; Califf, RM
Published in: Clinical Chemistry
January 1, 1995

Creatine kinase isoforms markers, including MB2 concentration, MB2/MB1 and MM3/MM1 ratios, and M(T) index (based on the 'tissue' M subunits), were measured in serial specimens from 207 patients receiving thrombolytic therapy followed by acute angiography. The slope of release showed a significant relation (P <0.05) between MB2 concentrations and patency, graded as TIMI 0 through TIMI 3; with regard to the precatheterization/baseline ratio, the MB2 concentrations, the MM3/MM1 ratio, and the M(T) index were all significantly related to graded patency (P <0.004). Patients having patency graded as either TIMI 2/3 (Open) or TIMI 0/1 (Closed) showed highly significant differences (P <0.03) in the slope of release and precatheterization/baseline ratio for all markers except the MB2/MB1 ratio. Defining Open as TIMI 3 and Closed as TIMI 0/1/2 showed very similar results. Despite these significant differences between the Open and Closed groups after thrombolytic therapy, none of the C index calculations (areas under ROC curves) for any of the isoform markers-either alone or combined-exceeded 0.70, suggesting that these markers have limited diagnostic utility for assessing patency.

Duke Scholars

Published In

Clinical Chemistry

DOI

ISSN

0009-9147

Publication Date

January 1, 1995

Volume

41

Issue

6

Start / End Page

844 / 852

Related Subject Headings

  • General Clinical Medicine
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
  • 1004 Medical Biotechnology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Christenson, R. H., Ohman, E. M., Topol, E. J., O’Hanesian, M. A., Sigmon, K. N., Duh, S. H., … Califf, R. M. (1995). Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. Clinical Chemistry, 41(6), 844–852. https://doi.org/10.1093/clinchem/41.6.844
Christenson, R. H., E. M. Ohman, E. J. Topol, M. A. O’Hanesian, K. N. Sigmon, S. H. Duh, D. Kereiakes, et al. “Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography.” Clinical Chemistry 41, no. 6 (January 1, 1995): 844–52. https://doi.org/10.1093/clinchem/41.6.844.
Christenson RH, Ohman EM, Topol EJ, O’Hanesian MA, Sigmon KN, Duh SH, et al. Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. Clinical Chemistry. 1995 Jan 1;41(6):844–52.
Christenson, R. H., et al. “Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography.” Clinical Chemistry, vol. 41, no. 6, Jan. 1995, pp. 844–52. Scopus, doi:10.1093/clinchem/41.6.844.
Christenson RH, Ohman EM, Topol EJ, O’Hanesian MA, Sigmon KN, Duh SH, Kereiakes D, Worley SJ, George BS, Pizzo CK, Wall TC, Califf RM. Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. Clinical Chemistry. 1995 Jan 1;41(6):844–852.

Published In

Clinical Chemistry

DOI

ISSN

0009-9147

Publication Date

January 1, 1995

Volume

41

Issue

6

Start / End Page

844 / 852

Related Subject Headings

  • General Clinical Medicine
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
  • 1004 Medical Biotechnology